we study the circulating T-follicular regulatory and T-follicular regulatory cells in autoimmune hemolytic anemia.
Patients diagnosed as autoimmune hemolytic anemia, primary or secondary, male or female, any age but not on treatment
Pregnancy or breast-feeding women
Patients treated with corticoids or immunosuppressant.
Patients with hematological malignance.
Patients with alloimmune hemolytic anemia as ABO incompatibility or transplant patients
The sample size is 50 (25 in each arm) but number of controls will be decreased and number of cases will be increased
Case-control
Retrospective
flowcytometry
Diagnostic testThe study of CD4,CD25,FOXP3 and PD-1 on peripheral blood sample
The proportion of circulating T-follicular helper and T-follicular regulatory in patients with Autoimmune Hemolytic Anemia (AIHA), at diagnosis and after treatment
Measure the ratio between the T- follicular helper and T-follicular regulatory
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
